Literature DB >> 8101767

Evidence for limited molecular genetic heterogeneity as defined by allelotyping and clonal analysis in nine metastatic breast carcinomas.

B A Bonsing1, P Devilee, A M Cleton-Jansen, N Kuipers-Dijkshoorn, G J Fleuren, C J Cornelisse.   

Abstract

To investigate genetic intratumor heterogeneity, 42 samples of nine primary breast carcinomas and 29 related lymph node metastases were examined for DNA ploidy status, allelotype, and X chromosome inactivation pattern. Two primary breast carcinomas showed DNA index heterogeneity and five contained a single DNA aneuploid tumor stemline, whereas the two remaining primary tumors were solely DNA diploid. Most primary DNA tumor stemlines recurred in lymph node metastases (9 of 11). The allelotype, constructed with 31 different probes mapping to 23 different chromosome arms showed allelic imbalances on nearly all chromosome arms investigated. All tumors contained multiple allelic imbalances (range, 3-12). An allelic imbalance present in a primary tumor was consistently present in all DNA samples of that primary tumor and also in all DNA samples of related lymph node metastases, irrespective of DNA index heterogeneity. X chromosome inactivation pattern analysis with probe M27 beta (DXS255) confirmed the presence of clonal tumor cell populations in these tumors at the time of diagnosis. Densitometry of autoradiograms, which by eye showed retention of heterozygosity, revealed a narrow clustering of allelic imbalance factors between 1.0 and 1.4. In contrast, autoradiograms visually showing an allelic imbalance exhibited a marked interprobe, intertumor and intratumor variation in allelic imbalance factors. No relation between densitometry results and DNA ploidy status was found. Thus, at the time of diagnosis, an advanced primary breast carcinoma consists of a clonal tumor cell population with an established complement of allelic imbalances in all parts of the primary tumor and in the related lymph node metastases. Secondary to the establishment of allelic imbalances, intratumor heterogeneity for the copy number of involved alleles may develop, which in turn probably precedes metastasis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8101767

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  Disseminated peritoneal leiomyomatosis. Clonality analysis by X chromosome inactivation and cytogenetics of a clinically benign smooth muscle proliferation.

Authors:  B J Quade; C M McLachlin; V Soto-Wright; J Zuckerman; G L Mutter; C C Morton
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

Review 2.  The role of estrogen receptors in breast cancer metastasis.

Authors:  S A Fuqua
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-10       Impact factor: 2.673

3.  Frequent genetic differences between matched primary and metastatic breast cancer provide an approach to identification of biomarkers for disease progression.

Authors:  Andrzej B Popławski; Michał Jankowski; Stephen W Erickson; Teresita Díaz de Ståhl; E Christopher Partridge; Chiquito Crasto; Jingyu Guo; John Gibson; Uwe Menzel; Carl Eg Bruder; Aneta Kaczmarczyk; Magdalena Benetkiewicz; Robin Andersson; Johanna Sandgren; Barbara Zegarska; Dariusz Bała; Ewa Srutek; David B Allison; Arkadiusz Piotrowski; Wojciech Zegarski; Jan P Dumanski
Journal:  Eur J Hum Genet       Date:  2010-01-06       Impact factor: 4.246

4.  Classical gene amplifications in human breast cancer are not associated with distant solid metastases.

Authors:  K Driouch; M H Champème; M Beuzelin; I Bièche; R Lidereau
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

5.  Molecular genetic evidence for unifocal origin of advanced epithelial ovarian cancer and for minor clonal divergence.

Authors:  E C Abeln; N J Kuipers-Dijkshoorn; E M Berns; S C Henzen-Logmans; G J Fleuren; C J Cornelisse
Journal:  Br J Cancer       Date:  1995-11       Impact factor: 7.640

6.  Allelic loss on chromosome band 18p11.3 occurs early and reveals heterogeneity in breast cancer progression.

Authors:  K Kittiniyom; K M Gorse; F Dalbegue; J H Lichy; J K Taubenberger; I F Newsham
Journal:  Breast Cancer Res       Date:  2001-02-12       Impact factor: 6.466

7.  Loss of heterozygosity at chromosome 9p in ductal carcinoma in situ and invasive carcinoma of the breast.

Authors:  K L Marsh; J M Varley
Journal:  Br J Cancer       Date:  1998-05       Impact factor: 7.640

8.  Longitudinal study of recurrent metastatic melanoma cell lines underscores the individuality of cancer biology.

Authors:  Zoltan Pos; Tara L Spivey; Hui Liu; Michele Sommariva; Jinguo Chen; John R Wunderlich; Giulia Parisi; Sara Tomei; Ben D Ayotte; David F Stroncek; Joel A Malek; Paul F Robbins; Licia Rivoltini; Michele Maio; Lotfi Chouchane; Ena Wang; Francesco M Marincola
Journal:  J Invest Dermatol       Date:  2013-11-22       Impact factor: 8.551

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.